•
Sep 30, 2022

Elevance Health Q3 2022 Earnings Report

Elevance Health reported strong financial performance with double-digit growth in revenue, operating earnings, and adjusted earnings per share.

Key Takeaways

Elevance Health reported a strong third quarter in 2022, with an 11.5% increase in operating revenue to $39.6 billion. GAAP net income was $6.68 per share, and adjusted net income was $7.53 per share. Medical enrollment reached 47.3 million members, a 2.2 million increase year-over-year.

GAAP net income was $6.68 per share, including net negative adjustment items of $0.85 per share; adjusted net income was $7.53 per share.

Operating revenue grew 11.5% year-over-year to $39.6 billion.

Operating gain increased 10.2% over the prior year quarter to $2.3 billion.

Medical enrollment increased by 2.2 million members year-over-year and 232 thousand members during the quarter, reaching 47.3 million members.

Total Revenue
$39.6B
Previous year: $35.5B
+11.5%
EPS
$7.53
Previous year: $6.79
+10.9%
Total Medical Membership
47.3M
Previous year: 45.1M
+4.9%
Gross Profit
$36.5B
Previous year: $9.18B
+297.8%
Cash and Equivalents
$8.87B
Previous year: $5.49B
+61.6%
Free Cash Flow
$4.62B
Previous year: $2.25B
+105.7%
Total Assets
$103B
Previous year: $98.1B
+5.1%

Elevance Health

Elevance Health

Elevance Health Revenue by Segment

Forward Guidance

The Company now expects GAAP net income to be greater than $25.33 per share, including approximately $3.62 per share of net unfavorable adjustment items. The Company now expects full-year adjusted net income to be greater than $28.95 per share.

Revenue & Expenses

Visualization of income flow from segment revenue to net income